Education
About Us
Working with TipRanks
Follow Us
Tong Ren Tang Technologies Co Ltd Class H (HK:1666)
:1666
1666 Stock Chart & Stats
HK$4.49
-HK$0.01(-0.20%)
At close: 4:00 PM EST
HK$4.49
-HK$0.01(-0.20%)
Day’s Range― - ―
52-Week RangeHK$4.40 - HK$5.52
Previous CloseN/A
Volume468.00K
Average Volume (3M)1.05M
Market Cap
HK$5.75B
Enterprise ValueHK$6.70B
Total Cash (Recent Filing)HK$5.15B
Total Debt (Recent Filing)HK$2.41B
Price to Earnings (P/E)12.4
Beta0.88
Next Earnings
Mar 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.38%
Share Statistics
EPS (TTM)0.29
Shares Outstanding628,704,000
10 Day Avg. Volume1,287,300
30 Day Avg. Volume1,053,233
Financial Highlights & Ratios
PEG Ratio-1.10
Price to Book (P/B)0.87
Price to Sales (P/S)0.86
P/FCF Ratio-39.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Tong Ren Tang Technologies Co News
1666 FAQ
What was Tong Ren Tang Technologies Co Ltd Class H’s price range in the past 12 months?
Tong Ren Tang Technologies Co Ltd Class H lowest stock price was HK$4.40 and its highest was HK$5.52 in the past 12 months.
What is Tong Ren Tang Technologies Co Ltd Class H’s market cap?
Tong Ren Tang Technologies Co Ltd Class H’s market cap is HK$5.75B.
When is Tong Ren Tang Technologies Co Ltd Class H’s upcoming earnings report date?
Tong Ren Tang Technologies Co Ltd Class H’s upcoming earnings report date is Mar 20, 2026 which is in 88 days.
How were Tong Ren Tang Technologies Co Ltd Class H’s earnings last quarter?
Tong Ren Tang Technologies Co Ltd Class H released its earnings results on Aug 26, 2025. The company reported HK$0.286 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.286.
Is Tong Ren Tang Technologies Co Ltd Class H overvalued?
According to Wall Street analysts Tong Ren Tang Technologies Co Ltd Class H’s price is currently Overvalued.
Does Tong Ren Tang Technologies Co Ltd Class H pay dividends?
Tong Ren Tang Technologies Co Ltd Class H pays a Annually dividend of HK$0.197 which represents an annual dividend yield of 4.38%. See more information on Tong Ren Tang Technologies Co Ltd Class H dividends here
What is Tong Ren Tang Technologies Co Ltd Class H’s EPS estimate?
Tong Ren Tang Technologies Co Ltd Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tong Ren Tang Technologies Co Ltd Class H have?
Tong Ren Tang Technologies Co Ltd Class H has 628,704,000 shares outstanding.
What happened to Tong Ren Tang Technologies Co Ltd Class H’s price movement after its last earnings report?
Tong Ren Tang Technologies Co Ltd Class H reported an EPS of HK$0.286 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.301%.
Which hedge fund is a major shareholder of Tong Ren Tang Technologies Co Ltd Class H?
Currently, no hedge funds are holding shares in HK:1666
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tong Ren Tang Technologies Co Ltd Class H
Tong Ren Tang Technologies Co (1666) is a leading enterprise in the traditional Chinese medicine sector, primarily engaged in the research, development, production, and distribution of a wide range of Chinese herbal medicines and health products. The company operates in various sectors, including pharmaceuticals, healthcare, and wellness products, leveraging its rich heritage and expertise in traditional Chinese medicine to deliver high-quality products that cater to both domestic and international markets.
Technical Analysis
Beijing Tong Ren Tang Chinese Medicine Co
―
China Traditional Chinese Medicine Holdings Co
―
Abbisko Cayman Limited
―
China Shineway Pharmaceutical Group Limited
―
Reliance Global Holdings Limited
―
Options Prices
Currently, No data available
---